Skip to main content
. Author manuscript; available in PMC: 2016 Jul 1.
Published in final edited form as: Radiat Res. 2015 Jun 26;184(1):14–23. doi: 10.1667/RR13927.1

TABLE 1.

Prospective Biomarker Proteins

Candidate Sample type
Species Method of detection Radiation dose (collection time point postirradiation)
TBI plasmaa Cell lineb PBL ex vivoc Blood ex vivod
ADAM9 Human Western blot PBL (7 Gy, 1 h)
Cell (0.5–4 Gy, 6–48 h)
ALBUMIN Human/mouse ELISA Blood (2–4 Gy, 2–6 h)
TBI plasma (1–8 Gy, 6–48 h)
α-AMYLASE Mouse ELISA Cell (8 Gy, 24 h)
Blood (8 Gy, 5 h)
TBI plasma (1–8 Gy, 6–72 h)
CUGBP1 Human Western blot Cell (2–7 Gy, 6–24 h)
CUGBP2 Human Western blot Cell (2–7 Gy, 6 h)
ENO1 Human Western blot PBL (7 Gy, 1 h)
Cell (0.5–4 Gy, 1–6 h)
FIBRINOGEN + Human/mouse ELISA Blood (8 Gy, 5 h)
TBI plasma (1–8 Gy, 24 h–1 week)
FMRP Human Western blot PBL (7 Gy, 1 h)
γH2AX + + Human/mouse ELISA PBL (2–8 Gy, 1–48 h)
Cell (4 Gy, 1–24 h)
IL1β Mouse ELISA e Partial-body irradiation (8 Gy, 24 h–1 week)
MMP2 Mouse ELISA TBI plasma (1–8 Gy, 24–72 h)
MMP3 Mouse ELISA TBI plasma (8 Gy, 24–72 h)
MMP9 + Mouse ELISA TBI plasma (1–8 Gy, 24–72 h)
MUC1 Human Western blot PBL (7 Gy, 1 h)
Cell (2–12 Gy, 2–24 h)
NSE Mouse ELISA TBI plasma (1–8 Gy, 24–72 h)
S100B Mouse ELISA TBI plasma (8 Gy, 24–72 h)
SAA + Mouse ELISA TBI plasma (1–8 Gy, 6 h–3 weeks)
ST3GAL1 Human Western blot PBL (2–8 Gy, 24–48 h)
Cell (0.5–8 Gy, 1–48 h)
Blood (2–8 Gy, 1–48 h)
STFR Human ELISA Blood (2–4 Gy, 2–24 h)
TRANSFERRIN Human/mouse ELISA Blood (2–4 Gy, 2–24 h)
TBI plasma (1–4 Gy, 24–72 h)
VEGF Mouse ELISA TBI plasma (1–8 Gy, 24–72 h)

Note. + = Antigen increase with irradiation; − = no response to irradiation; ≈ = not determined.

a

Plasma was harvested from TBI C57BL6 mice.

b

Cell lines of human origin were cultured and irradiated in vitro.

c

Human PBL were harvested, cultured and irradiated ex vivo.

d

Human blood was collected and irradiated ex vivo.

e

For this target C57BL6 mice were irradiated in a partial-body model to either head or trunk only.